Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autophagy Inhibition with Hydroxychloroquine in Breast Cancer
NCT01292408Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine in breast cancer, sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
hydroxychloroquine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01292408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01292408.